CELEBRATING 25 YEARS OF JCO

Commentary

Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress

Robert K. Oldham and Robert O. Dillman

JCO Apr 10 2008: 1774–1777. [Full Text] [PDF] [Romanian PDF] [From JCO 1983]

EDITORIALS

The "Other" Signaling of Trastuzumab: Antibodies Are Immunocompetent Drugs

Luca Gianni

JCO Apr 10 2008: 1778–1780. First published on Mar 17 2008; 10.1200/JCO.2007.15.7404. [Full Text] [PDF]

Defining the Optimal Schedule of Drug Administration: Art or Science?

Chris J. Twelves

JCO Apr 10 2008: 1781–1782. [Full Text] [PDF]

Bleomycin in Testicular Cancer: Will Pharmacogenomics Improve Treatment Regimens?

Carsten Bokemeyer

JCO Apr 10 2008: 1783–1785. [Full Text] [PDF]

Perioperative Risks of Bevacizumab and Other Biologic Agents for Hepatectomy: Theoretical or Evidence Based?

Anton J. Bilchik and J. Randolph Hecht

JCO Apr 10 2008: 1786–1788. [Full Text] [PDF]

ORIGINAL REPORTS
Breast Cancer
	Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
	Antonino Musolino, Nadia Naldi, Beatrice Bortesi, Debora Pezzuolo, Marzia Capelletti, Gabriele Missale, Diletta Laccabue, Alessandro Zerbini, Roberta Camisa, Giancarlo Bisagni, Tauro Maria Neri, and Andrea Ardizzoni
	JCO Apr 10 2008: 1789–1796. First published on Mar 17 2008; 10.1200/JCO.2007.14.8957. [Abstract] [Full Text] [PDF] [Chinese PDF]
	Phase I Study of a Novel Capecitabine Schedule Based on the Norton-Simon Mathematical Model in Patients With Metastatic Breast Cancer
	Tiffany A. Traina, Maria Theodoulou, Kimberly Feigin, Sujata Patil, K. Lee Tan, Charles Edwards, Ute Dugan, Larry Norton, and Clifford Hudis
	JCO Apr 10 2008: 1797–1802. [Abstract] [Full Text] [PDF]
	Occult Axillary Node Metastases in Breast Cancer Are Prognostically Significant: Results in 368 Node-Negative Patients With 20-Year Follow-Up
	Lee K. Tan, Dilip Giri, Amanda J. Hummer, Katherine S. Panageas, Edi Brogi, Larry Norton, Clifford Hudis, Patrick I. Borgen, and Hiram S. Cody, III
	JCO Apr 10 2008: 1803–1809. First published on Mar 10 2008; 10.1200/JCO.2007.12.6425. [Abstract] [Full Text] [PDF]
	Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
	Harold J. Burstein, Anthony D. Elias, Hope S. Rugo, Melody A. Cobleigh, Antonio C. Wolff, Peter D. Eisenberg, Mary Lehman, Bonne J. Adams, Carlo L. Bello, Samuel E. DePrimo, Charles M. Baum, and Kathy D. Miller
	JCO Apr 10 2008: 1810–1816. First published on Mar 17 2008; 10.1200/JCO.2007.14.5375. [Abstract] [Full Text] [PDF] [German PDF]

Genitourinary Cancer
	Variation in Bleomycin Hydrolase Gene Is Associated With Reduced Survival After Chemotherapy for Testicular Germ Cell Cancer
	Esther C. de Haas, Nynke Zwart, Coby Meijer, Janine Nuver, H. Marike Boezen, Albert J.H. Suurmeijer, Harald J. Hoekstra, Gerrit van der Steege, Dirk Th. Sleijfer, and Jourik A. Gietema
	JCO Apr 10 2008: 1817–1823. [Abstract] [Full Text] [PDF]
	Toremifene Improves Lipid Profiles in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase III Study
	Matthew R. Smith, S. Bruce Malkowicz, Franklin Chu, John Forrest, Paul Sieber, K. Gary Barnette, Domingo Rodriquez, and Mitchell S. Steiner
	JCO Apr 10 2008: 1824–1829. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer
	Brigit Gruenberger, Dietmar Tamandl, Johannes Schueller, Werner Scheithauer, Christoph Zielinski, Friedrich Herbst, and Thomas Gruenberger
	JCO Apr 10 2008: 1830–1835. [Abstract] [Full Text] [PDF] [Chinese PDF]

Molecular Oncology
	Effect of Molecular Therapeutics on Liver Regeneration in a Murine Model
	George Van Buren, II, Anthony D. Yang, Nikolaos A. Dallas, Michael J. Gray, Sherry J. Lim, Ling Xia, Fan Fan, Ray Somcio, Yan Wu, Daniel J. Hicklin, and Lee M. Ellis
	JCO Apr 10 2008: 1836–1842. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96
	Josep-María Ribera, Albert Oriol, Miguel-Angel Sanz, Mar Tormo, Pascual Fernández-Abellán, Eloy del Potro, Eugenia Abella, Javier Bueno, Ricardo Parody, Pilar Bastida, Carlos Grande, Inmaculada Heras, Concepción Bethencourt, Evarist Feliu, and Juan-José Ortega
	JCO Apr 10 2008: 1843–1849. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Risk of Subsequent Solid Tumors After Non-Hodgkin's Lymphoma: Effect of Diagnostic Age and Time Since Diagnosis
	Kari Hemminki, Per Lenner, Jan Sundquist, and Justo Lorenzo Bermejo
	JCO Apr 10 2008: 1850–1857. First published on Mar 17 2008; 10.1200/JCO.2007.14.6068. [Abstract] [Full Text] [PDF]
	Involved-Field Radiotherapy Before High-Dose Therapy and Autologous Stem-Cell Rescue in Diffuse Large-Cell Lymphoma: Long-Term Disease Control and Toxicity
	Bradford S. Hoppe, Craig H. Moskowitz, Daniel A. Filippa, Chaya S. Moskowitz, Tarun Kewalramani, Andrew D. Zelenetz, and Joachim Yahalom
	JCO Apr 10 2008: 1858–1864. First published on Mar 10 2008; 10.1200/JCO.2007.15.4773. [Abstract] [Full Text] [PDF] [Chinese PDF] [Publisher's Note]

Cancer Controls
	Lack of Community Insurance and Mammography Screening Rates Among Insured and Uninsured Women
	José A. Pagán, David A. Asch, Cynthia J. Brown, Carmen E. Guerra, and Katrina Armstrong
	JCO Apr 10 2008: 1865–1870. [Abstract] [Full Text] [PDF]

Thoracic Oncology
	Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non–Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials Group
	Scott A. Laurie, Isabelle Gauthier, Andrew Arnold, Frances A. Shepherd, Peter M. Ellis, Eric Chen, Glenwood Goss, Jean Powers, Wendy Walsh, Dongsheng Tu, Jane Robertson, Thomas A. Puchalski, and Lesley Seymour
	JCO Apr 10 2008: 1871–1878. [Abstract] [Full Text] [PDF]
	Phase III Trial Comparing Carboplatin, Paclitaxel, and Bexarotene With Carboplatin and Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT II
	George R. Blumenschein, Jr, Fadlo R. Khuri, Joachim von Pawel, Ulrich Gatzemeier, Wilson H. Miller, Jr, Robert M. Jotte, Jacques Le Treut, Show-Li Sun, Jinkun K. Zhang, Zofia E. Dziewanowska, and Andres Negro-Vilar
	JCO Apr 10 2008: 1879–1885. [Abstract] [Full Text] [PDF] [Chinese PDF]
	Randomized Phase III Trial Comparing Bexarotene (L1069-49)/Cisplatin/Vinorelbine With Cisplatin/Vinorelbine in Chemotherapy-Naïve Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: SPIRIT I
	Rodryg Ramlau, Petr Zatloukal, Jacek Jassem, Paul Schwarzenberger, Sergei V. Orlov, Maya Gottfried, Jose Rodrigues Pereira, Guillermo Temperley, Rosa Negro-Vilar, Samia Rahal, Joseph K. Zhang, Andres Negro-Vilar, and Zofia E. Dziewanowska
	JCO Apr 10 2008: 1886–1892. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Improvement in Oncology Practice Performance Through Voluntary Participation in the Quality Oncology Practice Initiative
	Joseph O. Jacobson, Michael N. Neuss, Kristen K. McNiff, Pamela Kadlubek, Leroy R. Thacker, II, Frank Song, Peter D. Eisenberg, and Joseph V. Simone
	JCO Apr 10 2008: 1893–1898. [Abstract] [Full Text] [PDF]

CORRESPONDENCE

Compassionate Approval Process for Experimental Gene-Based Products

Gladice Wallraven, John J. Nemunaitis, and Phillip B. Maples

JCO Apr 10 2008: 1899–1900. [Full Text] [PDF]

Could the Efficacy of Docetaxel in Prostate Cancer Patients Be Potentiated by Concomitant High-Dose Calcitriol Administration?

Alfredo Berruti, Marcello Tucci, Alessandra Mosca, Mara Ardine, Massimiliano Poggio, Andrea Saini, Lucianna Russo, Federica Vana, and Luigi Dogliotti

JCO Apr 10 2008: 1900–1901. [Full Text] [PDF]

In Reply

Tomasz M. Beer

JCO Apr 10 2008: 1901–1902. [Full Text] [PDF]

No Evidence for Taxane/Platinum Pharmacogenetic Markers: Just Lack of Power?

Werner Vach, Troels K. Bergmann, and Kim Brøsen

JCO Apr 10 2008: 1903–1904. [Full Text] [PDF]

In Reply

Jim Paul, Sharon Marsh, Howard L. McLeod, and Robert Brown

JCO Apr 10 2008: 1904–1905. [Full Text] [PDF]

Treatment of Venous Thrombosis in Patients With Intracranial Malignancies

Carl D. Atkins

JCO Apr 10 2008: 1905. [Full Text] [PDF]

In Reply

Alok A. Khorana, Charles W. Francis, Anna Falanga, and Gary H. Lyman

JCO Apr 10 2008: 1906–1907. [Full Text] [PDF]

Low Platelet Counts in Cancer Patients: Should Heparin for Venous Thromboembolism Prophylaxis Be Instituted?

Nishith K. Singh and Gaurav Sangwan

JCO Apr 10 2008: 1906. [Full Text] [PDF]

Capecitabine and Irinotecan As First-Line Treatment of Advanced Colorectal Cancer

Cornelis J.A. Punt and Miriam Koopman

JCO Apr 10 2008: 1907–1908. [Full Text] [PDF]

In Reply

Charles S. Fuchs, John Marshall, and José Barrueco

JCO Apr 10 2008: 1908–1909. [Full Text] [PDF]

Contralateral Prophylactic Mastectomy: Mind the Genetics

Evangelos Briasoulis and Dimitrios H. Roukos

JCO Apr 10 2008: 1909–1910. [Full Text] [PDF]

In Reply

Todd M. Tuttle, Elizabeth B. Habermann, and Beth A. Virnig

JCO Apr 10 2008: 1910. [Full Text] [PDF]

ERRATA

ERRATUM

JCO Apr 10 2008: 1911. [Full Text] [PDF]

ERRATUM

JCO Apr 10 2008: 1911. [Full Text] [PDF]

ERRATUM

JCO Apr 10 2008: 1911. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.